Monograph

S01EA05 - Brimonidine

Not porphyrinogenic

Rationale

Organic tartrate, probably not giving rise to significant systemic load.

Chemical description

Brimonidine tartrate, used in eye drops 2mg/mL to decrease the intraocular pressure in glaucoma. Plasma concentrations after 10 days use is very low, in the order of 0,06 Âµg/mL, but some accumulation can be noted on repeated installations.

Similar drugs

Explore alternative drugs in similar therapeutic classes S01E / S01EA or go back.

Tradenames

This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Show more details and information about the listed tradenames